NFSG
REGN icon

Newbridge Financial Services Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Newbridge Financial Services Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.3K Sell
63
-3
-5% -$2.04K ﹤0.01% 544
2026
Q1 		$51K Buy
66
+3
+5% +$2.3K 0.01% 418
2025
Q4 		$48.6K Hold
63
– – 0.01% 439
2025
Q3 		$35.4K Sell
63
-10
-14% -$5.65K 0.01% 588
2025
Q2 		$38.3K Sell
73
-4
-5% -$2.23K 0.01% 560
2025
Q1 		$48.8K Buy
77
+2
+3% +$1.38K 0.01% 374
2024
Q4 		$53.4K Sell
75
-76
-50% -$63.8K 0.01% 389
2024
Q3 		$159K Buy
151
+10
+7% +$11.1K 0.06% 173
2024
Q2 		$148K Sell
141
-2
-1% -$1.94K 0.06% 220
2024
Q1 		$138K Buy
143
+41
+40% +$39K 0.06% 242
2023
Q4 		$89.6K Sell
102
-10
-9% -$8.23K 0.04% 293
2023
Q3 		$92.2K Sell
112
-24
-18% -$18.9K 0.05% 314
2023
Q2 		$97.7K Sell
136
-26
-16% -$20K 0.05% 320
2023
Q1 		$133K Hold
162
– – 0.07% 267
2022
Q4 		$117K Sell
162
-30
-16% -$22.1K 0.07% 272
2022
Q3 		$132K Sell
192
-7
-4% -$4.41K 0.08% 249
2022
Q2 		$118K Sell
199
-108
-35% -$70.2K 0.07% 245
2022
Q1 		$214K Buy
307
+181
+144% +$115K 0.11% 190
2021
Q4 		$80K Buy
126
+34
+37% +$20.9K 0.04% 355
2021
Q3 		$56K Sell
92
-900
-91% -$559K 0.04% 383
2021
Q2 		$554K Sell
992
-397
-29% -$201K 0.34% 62
2021
Q1 		$657K Sell
1,389
-45
-3% -$21.9K 0.48% 40
2020
Q4 		$693K Buy
1,434
+230
+19% +$124K 0.57% 36
2020
Q3 		$674K Buy
+1,204
New +$730K 0.66% 28

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Newbridge Financial Services Group's REGN Position: Q2 2026 in Review

Newbridge Financial Services Group reduced its Regeneron Pharmaceuticals (REGN) stake by 4.5% in Q2 2026, selling an estimated $2.04K and leaving 63 shares worth $39.3K. The position accounts for ﹤0.01% of the portfolio, ranked #544.

Newbridge Financial Services Group first reported a position in REGN in Q3 2020 and has held it in 24 quarters since. The position peaked at $693K in Q4 2020. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Newbridge Financial Services Group held 63 shares of Regeneron Pharmaceuticals worth $39.3K as of Q2 2026.
  • Newbridge Financial Services Group sold 3 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.04K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #544 holding.
  • Newbridge Financial Services Group first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • Newbridge Financial Services Group's Regeneron Pharmaceuticals position peaked at $693K in Q4 2020.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.